2008
DOI: 10.3998/ark.5550190.0009.f20
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and in vitro antiproliferative activity of new benzothiazole derivatives

Abstract: A series of benzothiazole bearing piperazino-arylsulfonamides (5a-k), and arylthiol analogues (6a-j) as well as substituted benzothiazoles having sulfonamides (9b, 9l-n and 10) have been synthesized. All compounds were evaluated, in vitro, for their antiproliferative activity against a large panel of human tumor-derived cell lines. Compounds 5c, 5d, 5j, 6b, 6c and 6j were the most potent analogues in this series, showing activity against both cell lines derived from haematological and solid tumors (CC 50 range… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 37 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…36 The benzothiazole−piperazine backbone's anticancer properties have shown that arylsulfonamides and arylthiol derivatives are cytotoxic to hepatocellular (HepG-2), prostate (DU-145), breast (MCF-7), and CD4 + human acute Tlymphoblastic leukemia (CCRF-CEM) cell lines. 37 Novel benzothiazole−piperazine compounds were tested for cytotoxicity using colon (HCT-116), breast (MCF-7), and liver cancer cell lines. 38 These studies show that many substituted benzothiazole−piperazine compounds are active against cancer cell types.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…36 The benzothiazole−piperazine backbone's anticancer properties have shown that arylsulfonamides and arylthiol derivatives are cytotoxic to hepatocellular (HepG-2), prostate (DU-145), breast (MCF-7), and CD4 + human acute Tlymphoblastic leukemia (CCRF-CEM) cell lines. 37 Novel benzothiazole−piperazine compounds were tested for cytotoxicity using colon (HCT-116), breast (MCF-7), and liver cancer cell lines. 38 These studies show that many substituted benzothiazole−piperazine compounds are active against cancer cell types.…”
Section: Introductionmentioning
confidence: 99%
“…By blocking kinase proteins, these medicines caused senescent cell death . The benzothiazole–piperazine backbone’s anticancer properties have shown that arylsulfonamides and arylthiol derivatives are cytotoxic to hepatocellular (HepG-2), prostate (DU-145), breast (MCF-7), and CD4 + human acute T-lymphoblastic leukemia (CCRF-CEM) cell lines …”
Section: Introductionmentioning
confidence: 99%